Publications:

• Bhowmik S, Murukute SL, Badajena SR, Goyal A, Virutkar RR, Mohapatra P*. Selective Inter-clonal Interaction is Crucial for the Metastatic Phenotype of BRAF-inhibitor Resistant Melanoma. Molecular Oncology,  EACR25-1808, 2025. *Corresponding author

• Bhowmik S, Badajena SR, Murukute SL, Goyal A, Mohapatra P*. Inhibition of STAT3 activation obstructs metastasis and restores drug sensitivity in BRAF-inhibitor-resistant melanoma. ESMO Open, PP470, 2025. *Corresponding author

• Jiang X, Mohapatra P, Rossing M, Zheng W, Zbodakova O, Thatte JV, Sørensen CS, Le Phan TH, Brakebusch C. Nuclear N-WASP Induces Actin Polymerization in the Nucleus with Cortactin as an Essential Factor. Cells. 2025 Jan 6;14(1):59.

• Vaiphei KK, Prabakaran A, Snigdha S, Murkute SL, Mohapatra P, Sahoo RK, Batheja S, Gupta U, Puri A, Roy U, Alexander A. Impact of PEGylated liposomes on cytotoxicity of tamoxifen and piperine on MCF-7 human breast carcinoma cells. J Drug Deliv Sci Technol. 2024 Dec;102(Pt A):106331. 

• Goyal A, Murkute SL, Bhowmik S, Prasad CP, Mohapatra P*. Belling the "cat": Wnt/β-catenin signaling and its significance in future cancer therapies. Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189195.*Corresponding author

• Kudi P, Sen S, Murkute S, Mohapatra P, Ranjan OP. Quality by design (QbD) based approach for development of itraconazole-loaded transferosomes for skin cancer: in vitro, ex vivo and cell line studies. Drug Dev Ind Pharm. 2024. Sep 10:1-14.

• Sharma A, Jorvekar SB, Bhowmik S, Mohapatra P, Borkar RM. Comprehensive assessment of per and polyfluoroalkyl substances (PFAS) contamination in groundwater of Kamrup, Assam, India: occurrence, health risks, and metabolomic insights. Environ Sci Process Impacts. 2024 Sep 18;26(9):1601-1617. 

• Rathee M, Umar SM, Dev AJR, Kashyap A, Mathur SR, Gogia A, Mohapatra P, Prasad CP. Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer types. Mol Biol Rep. 2024 Jul 6;51(1):788.

• Srimayee S, Badajena SR, Akhtar N, Kar MK, Dey S, Mohapatra P*, Manna D*. Stimuli-responsive release of active anionophore from RGD-peptide-linked proanionophore. Chem Commun (Camb). 2023 Oct 24;59(85):12759-12762. *Corresponding author.

• Prasad CP, Tripathi SC, Kumar M, Mohapatra P. Passage number of cancer cell lines: Importance, intricacies, and way-forward. Biotechnol Bioeng. 2023 Aug;120(8):2049-2055. doi: 10.1002/bit.28496. Epub 2023 Jul 13.

• Patil PM, Poddar N, Parihar N, Sen S, Mohapatra P, Murty USN, Pemmaraju DB. Optoresponsive Pheophorbide-Silver based organometallic nanomaterials for high efficacy multimodal theranostics in Melanoma. Chemical Engineering Journal. 2023 Aug, 470, 144110. 

• Sharma PK, Choudhury D, Karanwad T, Mohapatra P, Murty US, Banerjee S. Curcumin nanoparticles as a multipurpose additive to achieve high-fidelity SLA-3D printing and controlled delivery. Biomater Adv. 2023 Oct;153:213527. Epub 2023 Jun 23. 

• Yadav V, Jobe N, Satapathy SR, Mohapatra P, Andersson T. Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling. Cancers (Basel). 2022 Dec 10;14(24):6077.

• Syed AM, Kundu S, Ram C, Kulhari U, Kumar A, Mugale MN, Mohapatra P, Murty US, Sahu BD. Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signalling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodelling in mice. Free Radic Biol Med. 2022 Jun; 186:17-30. Epub 2022 May 2. 

• Arundhathi JRD, Mathur SR, Gogia A, Deo SVS, Mohapatra P, Prasad CP. Metabolic changes in triple-negative breast cancer-focus on aerobic glycolysis. Mol Biol Rep. 2021 May;48(5):4733-4745. 

• Mohapatra P*, Yadav V, Toftdahl M, Andersson T. WNT5A-Induced Activation of the Protein Kinase C Substrate MARCKS Is Required for Melanoma Cell Invasion. Cancers (Basel). 2020 12(2):346. *Corresponding author. 

• Mohapatra P*, Prasad CP, Andersson T. Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells. Molecular Oncology. 2019; 13(2) 480-494. *Corresponding author.

• Prasad CP, Manchanda M, Mohapatra P, Andersson T. WNT5A as a therapeutic target in breast cancer. Cancer Metastasis Reviews. 2018; 37(4):767-778.

• Linnskog R*, Mohapatra P*, Moradi F, Prasad CP, Andersson T. Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells: Dual interference of this loop more effectively impairs melanoma cell invasion. Oncotarget. 2016; 7(25):37790-37802.

• Prasad CP*, Mohapatra P*, Andersson T. Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer? Cancers (Basel). 2015; 7(3):1900-24.

Full Publication Link:

https://pubmed.ncbi.nlm.nih.gov/?term=purusottam+mohapatra&sort=date&size=100